Your browser doesn't support javascript.
loading
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials.
Aroda, V R; Ahmann, A; Cariou, B; Chow, F; Davies, M J; Jódar, E; Mehta, R; Woo, V; Lingvay, I.
Affiliation
  • Aroda VR; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: varoda@bwh.harvard.edu.
  • Ahmann A; Harold Schnitzer Diabetes Health Center at Oregon Health and Science University, Portland, OR, USA. Electronic address: ahmanna@ohsu.edu.
  • Cariou B; L'institut du thorax, CHU de Nantes, CIC 1413, Inserm, Nantes, France. Electronic address: bertrand.cariou@univ-nantes.fr.
  • Chow F; Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong Kong. Electronic address: b410773@mailserv.cuhk.edu.hk.
  • Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, UK. Electronic address: melanie.davies@uhl-tr.nhs.uk.
  • Jódar E; Hospital Universitario Quirón Salud Madrid, Facultad de Ciencias de la Salud, Universidad Europea de Madrid, Madrid, Spain. Electronic address: esteban.jodar@gmail.com.
  • Mehta R; Unidad de Investigacón en Enfermedades Metabolicas, Departamento de Endocrinologia y Metablismo, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Mexico City, Mexico. Electronic address: roopamehta@yahoo.com.
  • Woo V; Section of Endocrinology and Metabolism, Health Sciences Centre, University of Manitoba, Winnipeg, MB, Canada. Electronic address: vwoo3@shaw.ca.
  • Lingvay I; UT Southwestern Medical Center, Dallas, TX, USA. Electronic address: Ildiko.Lingvay@UTSouthwestern.edu.
Diabetes Metab ; 45(5): 409-418, 2019 10.
Article de En | MEDLINE | ID: mdl-30615985
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Peptides glucagon-like / Incrétines / Récepteur du peptide-1 similaire au glucagon / Hypoglycémiants Type d'étude: Clinical_trials / Guideline / Risk_factors_studies Limites: Humans Langue: En Journal: Diabetes Metab Sujet du journal: ENDOCRINOLOGIA / METABOLISMO Année: 2019 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Peptides glucagon-like / Incrétines / Récepteur du peptide-1 similaire au glucagon / Hypoglycémiants Type d'étude: Clinical_trials / Guideline / Risk_factors_studies Limites: Humans Langue: En Journal: Diabetes Metab Sujet du journal: ENDOCRINOLOGIA / METABOLISMO Année: 2019 Type de document: Article